The intricate mechanisms underlying pathophysiology and progression of diabetes involve a complex interplay of genetic, metabolic, and immune factors. Type 1 diabetes results from autoimmune destruction of pancreatic beta cells, leading to absolute insulin deficiency, whereas type 2 diabetes is primarily driven by insulin resistance and progressive beta-cell dysfunction. Chronic hyperglycemia induces oxidative stress and inflammation, accelerating vascular and neural complications. Key signaling pathways, such as those involving insulin receptor substrates and glucose transporters, play crucial roles in disease development. Recent studies highlight the impact of gut microbiota, mitochondrial dysfunction, and lipid metabolism on diabetes progression. Understanding these molecular and cellular alterations is vital for developing targeted therapies aimed at preserving beta-cell function, enhancing insulin sensitivity, and preventing long-term complications.
Title : Diabetes reduction (pre-diabetes and type 2) with integrative medicine
F Buck Willis, IUHS School of Medicine, Saint Kitts and Nevis
Title : Adipose MTP deficiency protects against hepatic steatosis by upregulating PPAR activity
Sujith Rajan, NYU Long Island School of Medicine, United States
Title : Does winter melon (Benincasa hispida) improves nutritional values and ameliorating glycaemic parameters?
Wan Rosli Wan Ishak, Universiti Sains Malaysia, Malaysia
Title : Clinical applications of monitoring unmethylated insulin cfDNA associated with beta-cell death for diabetes and metabolic diseases
Clifford Morris, Kihealth, United States
Title : Diabetes and migration: Impact of internal displacement on the prevalence and management of diabetes in Les Cayes, South Haiti (2022-2024)
Berger Saintius, Field Epidemiology Training Program (FETP), Haiti
Title : Correlation between food insecurity and diabetes in the commune of Les Cayes (2021-2024)
Djeamsly Salomon, Field Epidemiology Training Program (FETP), Haiti